The Breast Cancer Research Foundation Inc

“The draft form 990 is reviewed by management. After any required edits, the return is provided to the foundation's audit committee for their review and approval for filing; the final form 990, as approved by the audit committee, is provided to each member of the board of directors for their approval prior to the ultimate filing with the internal revenue service.”

“The foundation has a conflict-of-interest policy which requires all directors, officers and staff to report any conflicts or potential conflicts to the chief operating officer, who will report any conflicts or potential conflicts to the audit committee. Any individual may also report conflicts or potential conflicts directly to the audit committee. The policy empowers the audit committee to evaluate conflict disclosures and take any actions necessary to determine the extent and nature of any actual or potential conflict and, if appropriate, investigate alternatives to the proposed transaction or arrangement. The foundation may not enter into a transaction in which there is an actual or potential conflict of interest unless it has been approved by the audit committee. If a conflict has been disclosed, the interested party must recuse themselves from any deliberation or vote on such transaction. The audit committee shall report to the board at least quarterly with respect to any conflict of interest and the resolution thereof. The foundation requires all directors, officers and staff to submit annual statements of compliance with the policy.”

“An annual review of compensation is performed by the executive committee (the "committee") for the president and ceo. This review includes an assessment of the president and ceo's performance which informs the final compensation decision in accordance with the president and ceo's employment contract. The annual review of compensation for all other key management is performed by the president and ceo. The compensation budget for all employees is part of the organizational budget which is approved by the finance and investment committee and brought to the full board for approval.”

“The breast cancer research foundation inc.'s governing documents, conflict of interest policy and financial statements are available upon request.”

“Breast cancer is a complex disease with no simple solution. Every diagnosis is unique and puts lives at risk. We must stop breast cancer in its tracks, and research is the answer. Founded in 1993 by evelyn h. Lauder, the breast cancer research foundation, inc. Is the largest private funder of breast cancer research in the world. We invest in a wide range of research - from prevention to metastasis - because each area of investigation informs another, propelling us toward the solutions we urgently need. We convene and connect the best minds in science - giving them the opportunity to pursue their most innovative ideas. Our combination of investment and cross-disciplinary collaboration accelerates the entire field and builds momentum for new discoveries. Bcrf - funded investigators have been behind every major breakthrough in breast cancer research, and the field is moving faster than ever.”

“Return of prior-year grant awards 44,065. Provision for uncollectible accounts -178,876.”